Moban and Pregnancy
In animal studies on Moban and pregnancy, the medication increased the risk of miscarriages when it was given to pregnant mice. Because of this potential risk, healthcare providers should only prescribe the drug if the benefits to the pregnant woman outweigh the risks to the unborn child. If you are taking Moban and pregnancy occurs, let your healthcare provider know immediately.
As of January 2010, the manufacturer of Moban has decided to stop making this medication. It is predicted that all current supplies will be depleted by June 2010. All people taking Moban should talk with their healthcare providers immediately about switching to a different medication.
Moban® (molindone hydrochloride) may not be safe for women who are pregnant, although the full risks are not known at this time. In animal studies, the drug increased the risk of miscarriages.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
In animal studies, giving Moban to pregnant mice slightly increased the risk of miscarriages. This problem was not seen in pregnant rats or rabbits, however. Some studies suggest that Moban does not increase the risk of miscarriages in animals at all.
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a pregnant woman if the healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.